Parkinson's Disease: Causes, Symptoms, and Treatments
This paper provides a broad overview of Parkinson's disease (PD), tracing its history from James Parkinson's 1817 essay to modern research. It examines the neurological basis of the disease — particularly its effect on dopamine production — as well as genetic and environmental risk factors such as pesticide exposure. The paper discusses common symptoms, the difficulty of early diagnosis, and the role of movement in slowing disease progression, illustrated through the case of dancer Pamela Quinn. It also addresses surgical treatment options such as pallidotomy and concludes with a call for greater social understanding of those living with PD.
- Introduction to Parkinson's Disease: History and basic overview of PD
- Causes and Risk Factors: Dopamine, genetics, and pesticide exposure
- Symptoms and Early Detection: Common symptoms including tremor and depression
- Living with Parkinson's: The Case of Pamela Quinn: Dancer uses movement to slow disease progression
- Diagnosis Challenges and Treatment Options: Misdiagnosis risks and pallidotomy surgery
- Conclusion: Hope for patients and call for social understanding
✍️ How to write this paper — guide, tools & examples ▾
What makes this paper effective
- It grounds abstract medical concepts in a compelling personal narrative — the case of Pamela Quinn — which makes the disease's human impact tangible and memorable.
- It balances scientific detail (dopamine deficiency, pallidotomy, pesticide research) with accessible language suitable for a general audience.
- It draws on multiple types of sources — medical journals, consumer health publications, and personal accounts — lending credibility across different dimensions of the topic.
Key academic technique demonstrated
The paper demonstrates effective use of a case study to support a broader argument. Rather than relying solely on statistics and clinical data, the author integrates Pamela Quinn's experience as evidence that lifestyle factors — specifically movement — can meaningfully slow PD's progression. This technique bridges the gap between empirical research and real-world application.
Structure breakdown
The paper opens with the disease's historical origins and moves logically through causes, symptoms, and diagnosis before presenting a personal case study. It then addresses medical treatments and closes with a social appeal. This progression — from general to specific, and from clinical to societal — creates a coherent and well-paced argument across six sections.
Introduction to Parkinson's Disease
All people contract a disease sooner or later, and their well-being depends on the severity of the respective malady. There are numerous diseases known to mankind, and some of them go back to the early ages, when people first became aware that illnesses exist and that they need to be treated. Parkinson's disease has been known since medieval times, but it was officially recognized in 1817 when James Parkinson wrote about it in his essay "An Essay on the Shaking Palsy."
Doctor James Parkinson originally called the disease "the shaking palsy." Because the doctor had dedicated much of his time to documenting its symptoms, people came to refer to the malady as Parkinson's disease.
Most people suffering from Parkinson's disease are unaware that they carry it until it reaches its later stages. The disease usually affects those who are over 50 years old, as it is rare in younger people. Generally, as the person who has the disease grows older, the disease also evolves and affects its carrier more severely. Parkinson's disease (PD) has various risk factors. Men are more likely to contract the disease than women, though scientists have not yet been able to determine what makes men more vulnerable.
It is possible for people to carry a genetic predisposition to the disease and to become ill because of several factors that create favorable conditions for its progression. PD mainly affects dopamine production in the brain. Dopamine is responsible for supporting motor function, and without it people experience severe movement problems. Approximately 80% of the dopamine found in a healthy person is absent in those suffering from PD. Medications that supplement dopamine have been developed and have proved effective, as the progression of PD has been slowed in patients who use them.
PD apparently progresses slowly during its first 15 years, but afterward it is very possible for it to evolve much more rapidly.
Works Cited
Franklin H. Silverman and Barbara Henry. "Depression: A Primary Symptom of Parkinson Disease?" The Journal of Rehabilitation, Vol. 55, 1989.
John Henkel. "Parkinson's Disease: New Treatments Slow Onslaught of Symptoms." FDA Consumer, Vol. 32, July–August 1998.
Pamela Quinn. "Struggling to Move: Parkinson's Disease Took Her Dance Away, but Dance Gave Back." Dance Magazine, Vol. 81, December 2007.
Renee Twombly. "Pesticides and Parkinson Disease." Environmental Health Perspectives, Vol. 112, 2004.
Create your account
Always verify citation format against your institution’s current style guide requirements.